(MENAFN- EIN Presswire) EINPresswire/ -- The Peptide Microarray Market is valued at USD 903.8 million in 2025 and is projected to reach USD 1,316.4 million by 2035, expanding at a 3.8% CAGR. Growth is ...

However, these royalty costs are usually paid at or after commercialization, and the PEGylation strategy may carve a potentially faster track through clinical testing than the naked peptide.

Unapproved peptide drugs have become a trendy new approach to building muscle, smoothing wrinkles and trying to live longer.

Creative Biolabs has recently upgraded its antiviral peptide services so as to aid in antiviral drug development. NY, UNITED STATES, December 11, 2024 /EINPresswire ...